Previously, Sun at al.3reported downregulation of NRF2 expression in hepatocellular carcinoma cells exposed to erastin, and argued that this NRF2 downregulation reflects the non-sensitivity of hepatocellular carcinoma cells to ferroptosis. This evidence concerns the gene NFE2L2 and hepatocellular carcinoma.